Implementation Issues in Tuberculosis/HIV Program Collaboration and Integration: 3 Case Studies
Open Access
- 1 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s1), S114-S123
- https://doi.org/10.1086/518664
Abstract
The many interactions between tuberculosis (TB) and human immunodeficiency virus (HIV) infection influence the design and implementation of programs to address the needs of patients living with or at risk for both diseases. Collaboration between national TB and HIV programs and some degree of integration of services at a local level have been advocated by the World Health Organization and other international bodies and are recognized as essential in areas where the 2 diseases are prevalent. However, in most settings, strategies to accomplish this are only beginning to reach the field where their impact will be made and the expectation of improving the outcome of both diseases realized. In this article, 3 such strategies, offering varying degrees of collaboration and integration, are described, 1 at a national level in Malawi and 2 at local sites in South Africa. These geographically and programmatically distinct experiences in TB/HIV service integration are instructive, illustrate common themes, and show that the strategy can be successful, but they also show that programmatic, medical, staffing, resource, and scale-up challenges remain. In addition, they indicate that, although broad program principles of TB/HIV service integration are essential, program designs and components may vary by country and even within countries, as a result of differing TB and HIV disease prevalences, resources, levels of expertise, and differences in program settings (urban vs. rural and/or primary vs. district vs. specialty site). Large national programs can successfully provide rapid, uniform and widespread change and implementation but also must negotiate the subtleties of intricacies of TB/HIV interactions, which confound a uniform “one size fits all” public health approach. Conversely, smaller demonstration projects, even with successful outcomes, must grapple with issues related to generalization of findings, wider implementation, and scale up, to benefit larger populations of those in need.Keywords
This publication has 16 references indexed in Scilit:
- Tuberculosis Infection Control in Resource‐Limited Settings in the Era of Expanding HIV Care and TreatmentThe Journal of Infectious Diseases, 2007
- HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect StormThe Journal of Infectious Diseases, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIVJournal of Antimicrobial Chemotherapy, 2006
- Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV‐infected Malawian adults with new smear‐positive tuberculosisTropical Medicine & International Health, 2005
- BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005HIV Medicine, 2005
- Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi modelTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Integrating tuberculosis and HIV care in the primary care setting in South AfricaTropical Medicine & International Health, 2004
- Tuberculosis in HIV-infected patients: a comprehensive reviewClinical Microbiology & Infection, 2004
- Implementing antiretroviral therapy in resource-constrained settingsAIDS, 2004